閉経後オステオポローシス(Post Menopausal Osteoporosis):グローバル臨床試験動向(2014年上半期)

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDHC2158CTIDB)
◆英語タイトル:Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014
◆発行会社/調査会社:GlobalData
◆商品コード:GDHC2158CTIDB
◆発行日:2014年5月26日
◆調査対象地域:グローバル
◆ページ数:192
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[閉経後オステオポローシス(Post Menopausal Osteoporosis):グローバル臨床試験動向(2014年上半期)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014

Summary

GlobalData’s clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014″ provides data on the Post Menopausal Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post Menopausal Osteoporosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Post Menopausal Osteoporosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents2
List of Tables 4
List of Figures 5
Introduction 6
Post Menopausal Osteoporosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Post Menopausal Osteoporosis 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Post Menopausal Osteoporosis Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
F. Hoffmann-La Roche Ltd. 34
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Amgen Inc. 40
Clinical Trial Overview of Amgen Inc. 40
Merck & Co., Inc. 43
Clinical Trial Overview of Merck & Co., Inc. 43
Sanofi 45
Clinical Trial Overview of Sanofi 45
GlaxoSmithKline plc 47
Clinical Trial Overview of GlaxoSmithKline plc 47
Pfizer Inc. 49
Clinical Trial Overview of Pfizer Inc. 49
Novartis AG 51
Clinical Trial Overview of Novartis AG 51
Radius Health, Inc. 53
Clinical Trial Overview of Radius Health, Inc. 53
Actavis plc 54
Clinical Trial Overview of Actavis plc 54
Clinical Trial Overview of Top Institutes / Government 55
Institut de Recherches Internationales Servier 55
Clinical Trial Overview of Institut de Recherches Internationales Servier 55
University of California, San Francisco 57
Clinical Trial Overview of University of California, San Francisco 57
University of Pittsburgh 58
Clinical Trial Overview of University of Pittsburgh 58
National Institute of Arthritis and Musculoskeletal and Skin Diseases 59
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 59
Mayo Clinic 60
Clinical Trial Overview of Mayo Clinic 60
National Heart, Lung, and Blood Institute 61
Clinical Trial Overview of National Heart, Lung, and Blood Institute 61
Massachusetts General Hospital 62
Clinical Trial Overview of Massachusetts General Hospital 62
National Center for Complementary and Alternative Medicine 63
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 63
Oregon Health and Science University 64
Clinical Trial Overview of Oregon Health and Science University 64
The National Institute of Diabetes and Digestive and Kidney Diseases 65
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 65
Five Key Clinical Profiles 66
Appendix 190
Abbreviations 190
Definitions 190
Research Methodology 191
Secondary Research 191
About GlobalData 192
Contact Us 192
Disclaimer 192
Source 192

List of Tables
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Post Menopausal Osteoporosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Post Menopausal Osteoporosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Post Menopausal Osteoporosis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 34
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 38
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 40
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 43
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 45
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 47
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 49
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 51
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radius Health, Inc., 2014* 53
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 54
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2014* 55
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 57
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 58
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 59
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 60
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 61
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 62
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014* 63
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 64
Post Menopausal Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 65

List of Figures
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Post Menopausal Osteoporosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 191

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 産業用酵素の世界市場2016
    The Global Industrial Enzymes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Industrial Enzymes industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain struc …
  • プロテック(PROTEC Co., Ltd.)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 脱毛剤(除毛剤)市場動向(~2017):ポーランド
    Synopsis The report presents detailed data on consumption trends in the Depilatories category in Poland, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers & acquisitions (of Skincare mar …
  • ヨルダンの個人障害保険・医療保険市場(~2017)
    "Trends and Opportunities in Jordan Personal Accident and Health Insurance Industry to 2017: Market Profile" is the result of extensive research into the personal accident and health insurance segment in Jordan. It provides insights into the market trends, market size, growth prospects and market ef …
  • LEDグローライトの世界市場
    Light-Emitting Diode (LED) grow light is a specialized kind of LED lighting system, which is witnessing increased adoption across all application areas. This is primarily due to the capacity of this technology to produce food in controlled environment through vertical farming, commercial greenhouse, …
  • 世界及び中国のロイコボリンカルシウム市場2015
    The 'Global and Chinese Leucovorin Calcium Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Leucovorin Calcium industry with a focus on the Chinese market. The report provides key statistics on the market status of the Leucovorin Cal …
  • Survivin Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)
    DelveInsight’s,“Survivin Inhibitors-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Survivin Inhibitors. This report …
  • 緑十字ホールディングス(Green Cross Holdings)企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • アラビアガムの世界市場
    The Global Gum Arabic Market is estimated to grow at a CAGR of 6.7% during the forecast period. Gum Arabic is known for its numerous applications, such as a thickener, gelling agent, coating agent, stabilizer, texturants, and fat replacers. Some of the most common food applications of gum arabic inc …
  • 耐熱性コンベヤベルトの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Heat Resistant Conveying Belt Revenue, means the sales value of Heat Resistant Conveying Belt This report studies sales (consumption) of Heat Resistant Conveying Belt in Global market, especially in United States, China, Europe and Japan, focuses on top players …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHC2158CTIDB )"閉経後オステオポローシス(Post Menopausal Osteoporosis):グローバル臨床試験動向(2014年上半期)" (英文:Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。